About: Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2?
Creator	Courtet, P Durand, M Molès, J Nobile, B Olié, E Nagot, N Nobile, Bénédicte Van De Perre, P
Source	PMC
abstract	covid:cd4e00e9dce47fd1e89fec88b9eed122588a0c38#abstract
has issue date	2020-07-25(xsd:dateTime)
bibo:doi	10.1016/j.schres.2020.07.015
has license	no-cc
sha1sum (hex)	cd4e00e9dce47fd1e89fec88b9eed122588a0c38
schema:url	https://doi.org/10.1016/j.schres.2020.07.015
resource representing a document's title	Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2?
has PubMed Central identifier	PMC7381925
schema:publication	Schizophr Res
resource representing a document's body	covid:cd4e00e9dce47fd1e89fec88b9eed122588a0c38#body_text
is schema:about of	named entity 'CITE' named entity 'antipsychotic' named entity 'SARS-CoV-2' named entity 'potential treatment' named entity 'potential treatment' named entity 'SARS-CoV-2' named entity 'cationic' named entity 'cytokines' named entity 'endocytic pathway' named entity 'CPZ' named entity 'nausea' named entity 'long-term' named entity 'inflammatory markers' named entity 'RCT' named entity 'intensive care units' named entity 'encephalitis' named entity 'CPZ' named entity 'low pH' named entity 'infection' named entity 'Clathrin-Mediated Endocytosis' named entity 'adenovirus' named entity 'vesicular' named entity 'SARS-CoV-2' named entity 'pre-exposure prophylaxis' named entity 'Egypt' named entity 'infection rate' named entity 'France' named entity 'blood brain barrier' named entity 'MERS-CoV' named entity 'Severe Acute Respiratory Syndrome' named entity 'CNS' named entity 'lungs' named entity 'COVID-19' named entity 'inflammatory cytokines' named entity 'amphiphilic properties' named entity 'CME' named entity 'CPZ' named entity 'IL-6' named entity 'adverse effects' named entity 'anti-inflammatory' named entity 'TNFα' named entity 'inflammation' named entity 'infection' named entity 'inflammation' named entity 'CPZ' named entity 'antiviral' named entity 'CPZ' named entity 'CPZ' named entity 'proteases' named entity 'anesthesia' named entity 'IL-10' named entity 'protein' named entity 'virus' named entity 'viral load' named entity 'CME' named entity 'CPZ' named entity 'electrocardiogram' named entity 'protein' named entity 'endotoxins' named entity 'cultured cells' named entity 'CME' named entity 'infection' named entity 'infection' named entity 'reduce inflammation' named entity 'CPZ' named entity 'SARS-CoV-2' named entity 'plasma' named entity 'chlorpromazine' named entity 'mice' named entity 'SARS-CoV-2' named entity 'antipsychotic medication' named entity 'anti-inflammatory' named entity 'neurological' named entity 'coronaviruses' named entity 'prognosis' named entity 'Enveloped viruses'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software